Suppr超能文献

肾活检中淀粉样变性的分型:诊断陷阱

Typing of amyloidosis in renal biopsies: diagnostic pitfalls.

作者信息

Satoskar Anjali A, Burdge Kelly, Cowden Daniel J, Nadasdy Gyongyi M, Hebert Lee A, Nadasdy Tibor

机构信息

Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.

出版信息

Arch Pathol Lab Med. 2007 Jun;131(6):917-22. doi: 10.5858/2007-131-917-TOAIRB.

Abstract

CONTEXT

Amyloidosis represents a group of diseases with extracellular deposition of congophilic fibrils of similar morphology but differing chemical composition. The types commonly involving the kidney are AL (light chain amyloid) and AA (serum amyloid A). Familial amyloidosis can also affect the kidney, but we have not encountered such a case during the study period. Distinguishing between the AL and AA forms of amyloid is clinically important because of the different treatments and outcomes. The classification of amyloidosis is made by immunostaining with antibodies to kappa and lambda immunoglobulin light chains and for serum amyloid A protein.

OBJECTIVE

To draw attention to the nonspecific immunofluorescence staining patterns in renal biopsies with amyloidosis, causing potential diagnostic pitfalls.

DESIGN

Renal biopsies from 15 patients, including 13 cases of AL and 2 cases of AA amyloidosis, were studied. Immunofluorescence staining with routine antibody panel and immunoperoxidase staining for amyloid A were performed.

RESULTS

Of the 13 cases of AL amyloidosis, 2 cases showed little difference in staining intensity between kappa and lambda light chains (2+ and 3+, respectively) and 4 cases showed only moderate intensity (2+) of the predominant light chain. The 2 cases diagnosed as AA amyloidosis also exhibited staining for light chains. One case had strong (3+) signal for kappa and moderate (2+) for lambda light chain, while the other showed weaker staining.

CONCLUSIONS

Immunofluorescence staining for immunoglobin light chains on renal biopsy, as the first step to differentiate between AL and AA amyloidosis, may sometimes be inconclusive or even misleading. Applying amyloid A immunostain on a routine basis and detailed clinical history are essential to avoid misclassification.

摘要

背景

淀粉样变性是一组疾病,其细胞外沉积有形态相似但化学成分不同的嗜刚果红纤维。常见累及肾脏的类型为AL(轻链淀粉样蛋白)和AA(血清淀粉样蛋白A)。家族性淀粉样变性也可累及肾脏,但在研究期间我们未遇到此类病例。由于治疗方法和预后不同,区分AL型和AA型淀粉样变性在临床上很重要。淀粉样变性的分类通过用抗κ和λ免疫球蛋白轻链以及血清淀粉样蛋白A蛋白的抗体进行免疫染色来确定。

目的

提醒注意淀粉样变性肾活检中非特异性免疫荧光染色模式,这可能导致潜在的诊断陷阱。

设计

对15例患者的肾活检组织进行研究,其中包括13例AL型和2例AA型淀粉样变性。采用常规抗体组合进行免疫荧光染色,并对淀粉样蛋白A进行免疫过氧化物酶染色。

结果

在13例AL型淀粉样变性中,2例κ和λ轻链染色强度差异不大(分别为2+和3+),4例仅主要轻链呈中等强度(2+)染色。诊断为AA型淀粉样变性的2例也显示轻链染色。1例κ轻链呈强阳性(3+)信号,λ轻链呈中等阳性(2+)信号,另一例染色较弱。

结论

肾活检免疫球蛋白轻链免疫荧光染色作为区分AL型和AA型淀粉样变性的第一步,有时可能无法得出结论甚至产生误导。常规应用淀粉样蛋白A免疫染色和详细的临床病史对于避免错误分类至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验